{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:41:12Z","timestamp":1787164872737,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbmt.2020.04.030","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T03:00:46Z","timestamp":1589598046000},"page":"1589-1596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma"],"prefix":"10.1016","volume":"26","author":[{"given":"Felix","family":"Krummradt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kriegsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kriegsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_4","key":"10.1016\/j.bbmt.2020.04.030_bib0001","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","article-title":"Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Moreau","year":"2017","journal-title":"Ann Oncol."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0002","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.18.02096","article-title":"Treatment of multiple myeloma: ASCO and CCO Joint Clinical Practice Guideline","volume":"37","author":"Mikhael","year":"2019","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0003","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/s41409-019-0465-9","article-title":"The EBMT Activity Survey Report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies","volume":"54","author":"Passweg","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0004","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bmt.2014.55","article-title":"Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation","volume":"49","author":"Passweg","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MOH.0b013e328364f573","article-title":"Hematopoietic stem cell transplantation activity in Europe","volume":"20","author":"Gratwohl","year":"2013","journal-title":"Curr Opin Hematol."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0006","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bmt.1703013","article-title":"High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan\/cyclophosphamide with autologous stem cell transplantation in multiple myeloma","volume":"27","author":"Huijgens","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0007","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.31.5515","article-title":"Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma","volume":"28","author":"Regelink","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0008","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0009","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3109\/10428194.2013.773998","article-title":"Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation","volume":"54","author":"Auner","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2013.01.004","article-title":"Salvage second hematopoietic cell transplantation in myeloma","volume":"19","author":"Michaelis","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0011","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbmt.2012.11.013","article-title":"Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma","volume":"19","author":"Lemieux","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000478911","article-title":"Platelet count before peripheral blood stem cell mobilization is associated with the need for plerixafor but not with the collection result","volume":"45","author":"Baertsch","year":"2018","journal-title":"Transfus Med Hemother."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0013","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0014","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMoa1606038","article-title":"Daratumumab, bortezomib, and dexamethasone for multiple myeloma","volume":"375","author":"Palumbo","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1607751","article-title":"Daratumumab, lenalidomide, and dexamethasone for multiple myeloma","volume":"375","author":"Dimopoulos","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0016","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0017","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1200\/EDBK_200889","article-title":"CAR T cells and other cellular therapies for multiple myeloma: 2018 update","volume":"38:","author":"Cohen","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0018","unstructured":"Bundes\u00e4erztekammer. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (H\u00e4motherapie) \u2013 Zweite Richtlinienanpassung 2010. Available at:https:\/\/www.laekh.de\/images\/Aerzte\/QV\/Transfusionswesen_Haemotherapie\/Richtlinie_zur_Gewinnung_Blut_Haemotherapie.pdf. Accessed June 24, 2020."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0019","unstructured":"Bundes\u00e4erztekammer. Richtlinie zur Herstellung und Anwendung von h\u00e4matopoetischen Stammzellzubereitungen. Available at:https:\/\/www.bundesaerztekammer.de\/aerzte\/medizin-ethik\/wissenschaftlicher-beirat\/veroeffentlichungen\/haemotherapietransfusionsmedizin\/haematopoetischen-stammzellzubereitung\/. Accessed June 24, 2020."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0020","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie (DGHO). Gemeinsame Stellungnahme der Fachgesellschaften DGTI, DGHO und GPOH zu Genehmigungsverfahren von Stammzellzubereitungen. Available at: https:\/\/www.dgho.de\/publikationen\/stellungnahmen\/bundesoberbehoerden\/genehmigungsverfahren_stammzellzubereitungen. Accessed June 24, 2020."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0021","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2018.09.013","article-title":"Collection, cryostorage, transplantation, and disposal of hematopoietic stem cell products","volume":"25","author":"Kriegsmann","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0022","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.bbmt.2018.04.007","article-title":"Analysis of clinical factors and outcomes associated with nonuse of collected peripheral blood stem cells for autologous stem cell transplants in transplant-eligible patients with multiple myeloma","volume":"24","author":"Kansagra","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcyt.2013.07.001","article-title":"Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey","volume":"16","author":"Olivieri","year":"2014","journal-title":"Cytotherapy."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0024","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bmt.2015.13","article-title":"Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy","volume":"50","author":"Phipps","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mayocp.2017.01.003","article-title":"Therapy for relapsed multiple myeloma: guidelines from the Mayo stratification for myeloma and risk-adapted therapy","volume":"92","author":"Dingli","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/146532402317381839","article-title":"The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem cell transplantation: a survey of European practice","volume":"4","author":"Pottinger","year":"2002","journal-title":"Cytotherapy."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0027","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jcyt.2017.12.005","article-title":"Handling, processing and disposal of stem cell products in Europe: a survey by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation","volume":"20","author":"Holbro","year":"2018","journal-title":"Cytotherapy."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0028","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0029","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbmt.2009.11.012","article-title":"Poor mobilization of hematopoietic stem cells\u2014definitions, incidence, risk factors, and impact on outcome of autologous transplantation","volume":"16","author":"Wuchter","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbmt.2009.02.011","article-title":"Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma","volume":"15","author":"Popat","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0031","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/sj.leu.2405035","article-title":"Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients","volume":"22","author":"Mazumder","year":"2008","journal-title":"Leukemia."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0032","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.transci.2013.07.025","volume":"49","author":"Pierelli","year":"2013","journal-title":"Transfus Apher Sci."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0034","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.bbmt.2019.12.092","article-title":"Value and cost effectiveness of storing peripheral blood progenitor cells for salvage autologous stem cell transplant in multiple myeloma","volume":"26","author":"Ahmed","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2020.04.030_bib0035","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1111\/trf.12619","article-title":"A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel","volume":"54","author":"Perseghin","year":"2014","journal-title":"Transfusion."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:12:13Z","timestamp":1761059533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120302858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1083879120302858"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.030","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}